Deep-Track-Capital-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "AKRO",
  "EWTX",
  "INSM",
  "APLS",
  "ANIP",
  "ABVX",
  "GLPG",
  "DVAX",
  "NVAX",
  "BCAX",
  "BCYC",
  "OLMA",
  "GPCR",
  "RAPP",
  "TERN",
  "NRIX",
  "MNMD",
  "TECX",
  "NGNE",
  "SAGE",
  "ALGS",
  "ALLK",
  "AVTX",
  "GERN",
  "SYRE",
  "AUTL",
  "TARS",
  "GH",
  "IVVD",
  "KRRO",
  null,
  null,
  "OKUR",
  "SEPN",
  "IONS",
  "CYBN",
  "GHRS",
  "ZURA",
  "AMGN",
  "UPB",
  "RAPT",
  "PTGX",
  "MBX",
  "RGLS",
  "PLRX",
  "ETNB",
  "DYN",
  "SRPT",
  null,
  null,
  "CMPS",
  "CNTX",
  "IMCR",
  "IKNA",
  "INO",
  "VRDN",
  "XENE",
  "XNCR",
  "ORKA",
  null,
  "RARE",
  "IMVT",
  "PCVX",
  "BEAM",
  "BBIO",
  "CLDX",
  "CYTK",
  "DNTH"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 69
Total Value: 3088173822
Accession Number: 0001856083-25-000002
Form Type: 13F-HR
CIK: deep-track-capital-lp
Manager Name: Deep-Track-Capital-Lp

Data Enrichment

93% identified

64 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

69 positions • $3.1B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 4

Sort by:

46116X101

Shares:2.0M

Value:$263.8M

% of Portfolio:8.5% ($263.8M/$3.1B)

Guardant Health, Inc.

GH|40131M109

Shares:5.4M

Value:$231.9M

% of Portfolio:7.5% ($231.9M/$3.1B)

DYNAVAX TECHNOLOGIES CORP

DVAX|268158201

Shares:17.8M

Value:$230.8M

% of Portfolio:7.5% ($230.8M/$3.1B)

Immunovant, Inc.

IMVT|45258J102

Shares:9.5M

Value:$162.4M

% of Portfolio:5.3% ($162.4M/$3.1B)

Protagonist Therapeutics, Inc

PTGX|74366E102

Shares:3.0M

Value:$145.1M

% of Portfolio:4.7% ($145.1M/$3.1B)

IONIS PHARMACEUTICALS INC

IONS|462222100

Shares:4.6M

Value:$137.7M

% of Portfolio:4.5% ($137.7M/$3.1B)

Akero Therapeutics, Inc.

AKRO|00973Y108

Shares:3.2M

Value:$130.0M

% of Portfolio:4.2% ($130.0M/$3.1B)

CYTOKINETICS INC

CYTK|23282W605

Shares:3.1M

Value:$123.5M

% of Portfolio:4.0% ($123.5M/$3.1B)

Apellis Pharmaceuticals, Inc.

APLS|03753U106

Shares:5.0M

Value:$109.3M

% of Portfolio:3.5% ($109.3M/$3.1B)

OCULAR THERAPEUTIX, INC

OCUL|67576A100

Shares:14.3M

Value:$104.8M

% of Portfolio:3.4% ($104.8M/$3.1B)

BridgeBio Pharma, Inc.

BBIO|10806X102

Shares:2.8M

Value:$96.8M

% of Portfolio:3.1% ($96.8M/$3.1B)

Tarsus Pharmaceuticals, Inc.

TARS|87650L103

Shares:1.5M

Value:$76.2M

% of Portfolio:2.5% ($76.2M/$3.1B)

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:5.4M

Value:$72.5M

% of Portfolio:2.3% ($72.5M/$3.1B)

Structure Therapeutics Inc.

GPCR|86366E106

Shares:4.1M

Value:$71.0M

% of Portfolio:2.3% ($71.0M/$3.1B)

89bio, Inc.

ETNB|282559103

Shares:9.3M

Value:$67.7M

% of Portfolio:2.2% ($67.7M/$3.1B)

Nurix Therapeutics, Inc.

NRIX|67080M103

Shares:5.5M

Value:$65.3M

% of Portfolio:2.1% ($65.3M/$3.1B)

GERON CORP

GERN|374163103

Shares:38.2M

Value:$60.7M

% of Portfolio:2.0% ($60.7M/$3.1B)

Sarepta Therapeutics, Inc.

SRPT|803607100

Shares:899.7K

Value:$57.4M

% of Portfolio:1.9% ($57.4M/$3.1B)

Ultragenyx Pharmaceutical Inc.

RARE|90400D108

Shares:1.4M

Value:$48.9M

% of Portfolio:1.6% ($48.9M/$3.1B)

ANI PHARMACEUTICALS INC

ANIP|00182C103

Shares:700.0K

Value:$46.9M

% of Portfolio:1.5% ($46.9M/$3.1B)

Instrument	Shares		Other Manager	Value	% of Portfolio
(cusip46116X101)✕	2.0M	QoQ 0.00% (+0) YoY +33.33% (+500.0K)	All Managers (Combined)	$263.8M	8.5% ($263.8M/$3.1B)	QoQ +57.95% (+$96.8M) YoY +154.18% (+$160.0M)
Guardant Health, Inc.(GHcusip40131M109)	5.4M	QoQ -15.20% (-975.8K) YoY -9.27% (-556.3K)	All Managers (Combined)	$231.9M	7.5% ($231.9M/$3.1B)	QoQ +18.24% (-$35.8M) YoY +87.35% (-$108.1M)
DYNAVAX TECHNOLOGIES CORP(DVAXcusip268158201)	17.8M	QoQ 0.00% (+0) YoY +94.61% (+8.6M)	All Managers (Combined)	$230.8M	7.5% ($230.8M/$3.1B)	QoQ +1.56% (+$3.6M) YoY +103.40% (+$117.3M)
Immunovant, Inc.(IMVTcusip45258J102)	9.5M	QoQ +58.33% (+3.5M) YoY +1825.60% (+9.0M)	All Managers (Combined)	$162.4M	5.3% ($162.4M/$3.1B)	QoQ +9.24% (+$13.7M) YoY +918.52% (+$146.4M)
Protagonist Therapeutics, Inc(PTGXcusip74366E102)	3.0M	QoQ +200.00% (+2.0M) YoY NEW(+3.0M)	All Managers (Combined)	$145.1M	4.7% ($145.1M/$3.1B)	QoQ +275.85% (+$106.5M) YoY NEW(+$145.1M)
IONIS PHARMACEUTICALS INC(IONScusip462222100)	4.6M	QoQ +136.00% (+2.6M) YoY +232.31% (+3.2M)	All Managers (Combined)	$137.7M	4.5% ($137.7M/$3.1B)	QoQ +103.67% (+$70.1M) YoY +131.27% (+$78.2M)
Akero Therapeutics, Inc.(AKROcusip00973Y108)	3.2M	QoQ +115.45% (+1.7M) YoY NEW(+3.2M)	All Managers (Combined)	$130.0M	4.2% ($130.0M/$3.1B)	QoQ +213.50% (+$88.5M) YoY NEW(+$130.0M)
CYTOKINETICS INC(CYTKcusip23282W605)	3.1M	QoQ +22.95% (+573.9K) YoY NEW(+3.1M)	All Managers (Combined)	$123.5M	4.0% ($123.5M/$3.1B)	QoQ +5.04% (+$5.9M) YoY NEW(+$123.5M)
Apellis Pharmaceuticals, Inc.(APLScusip03753U106)	5.0M	QoQ +16.96% (-725.1K) YoY +400.00% (+4.0M)	All Managers (Combined)	$109.3M	3.5% ($109.3M/$3.1B)	QoQ -19.83% (-$27.1M) YoY +86.03% (+$50.6M)
OCULAR THERAPEUTIX, INC(OCULcusip67576A100)	14.3M	QoQ +11.35% (-1.5M) YoY +12.36% (-1.6M)	All Managers (Combined)	$104.8M	3.4% ($104.8M/$3.1B)	QoQ -4.41% (-$4.8M) YoY -9.49% (-$11.0M)
BridgeBio Pharma, Inc.(BBIOcusip10806X102)	2.8M	QoQ +241.81% (+2.0M) YoY NEW(+2.8M)	All Managers (Combined)	$96.8M	3.1% ($96.8M/$3.1B)	QoQ +330.62% (+$74.3M) YoY NEW(+$96.8M)
Tarsus Pharmaceuticals, Inc.(TARScusip87650L103)	1.5M	QoQ NEW(+1.5M) YoY NEW(+1.5M)	All Managers (Combined)	$76.2M	2.5% ($76.2M/$3.1B)	QoQ NEW(+$76.2M) YoY NEW(+$76.2M)
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	5.4M	QoQ +18.96% (-857.7K) YoY +55.68% (+1.9M)	All Managers (Combined)	$72.5M	2.3% ($72.5M/$3.1B)	QoQ -16.34% (-$14.2M) YoY +19.85% (+$12.0M)
Structure Therapeutics Inc.(GPCRcusip86366E106)	4.1M	QoQ +46.42% (-1.3M) YoY +10115.01% (+4.1M)	All Managers (Combined)	$71.0M	2.3% ($71.0M/$3.1B)	QoQ -6.53% (-$5.0M) YoY +4025.56% (+$69.3M)
89bio, Inc.(ETNBcusip282559103)	9.3M	QoQ +43.80% (+2.8M) YoY NEW(+9.3M)	All Managers (Combined)	$67.7M	2.2% ($67.7M/$3.1B)	QoQ +33.69% (+$17.1M) YoY NEW(+$67.7M)
Nurix Therapeutics, Inc.(NRIXcusip67080M103)	5.5M	QoQ +83.33% (+2.5M) YoY +83.46% (+2.5M)	All Managers (Combined)	$65.3M	2.1% ($65.3M/$3.1B)	QoQ +15.60% (+$8.8M) YoY +48.27% (+$21.3M)
GERON CORP(GERNcusip374163103)	38.2M	QoQ +851.72% (+34.2M) YoY +25.14% (-7.7M)	All Managers (Combined)	$60.7M	2.0% ($60.7M/$3.1B)	QoQ +327.46% (+$46.5M) YoY -39.70% (-$40.0M)
Sarepta Therapeutics, Inc.(SRPTcusip803607100)	899.7K	QoQ NEW(+899.7K) YoY NEW(+899.7K)	All Managers (Combined)	$57.4M	1.9% ($57.4M/$3.1B)	QoQ NEW(+$57.4M) YoY NEW(+$57.4M)
Ultragenyx Pharmaceutical Inc.(RAREcusip90400D108)	1.4M	QoQ +106.57% (+696.5K) YoY +704.60% (+1.2M)	All Managers (Combined)	$48.9M	1.6% ($48.9M/$3.1B)	QoQ +77.80% (+$21.4M) YoY +524.00% (+$41.0M)
ANI PHARMACEUTICALS INC(ANIPcusip00182C103)	700.0K	QoQ +7.85% (+51.0K) YoY -14.84% (-122.0K)	All Managers (Combined)	$46.9M	1.5% ($46.9M/$3.1B)	QoQ +30.61% (+$11.0M) YoY -17.52% (-$10.0M)